.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Covington
US Department of Justice
Argus Health
Accenture
Mallinckrodt
Baxter
Johnson and Johnson
Queensland Health
Teva

Generated: June 26, 2017

DrugPatentWatch Database Preview

VALSARTAN AND HYDROCHLOROTHIAZIDE Drug Profile

« Back to Dashboard

Which patents cover Valsartan And Hydrochlorothiazide, and when can generic versions of Valsartan And Hydrochlorothiazide launch?

Valsartan And Hydrochlorothiazide is a drug marketed by Aurobindo Pharma Ltd, Watson Labs Teva, Mylan Pharms Inc, Apotex Inc, Macleods Pharms Ltd, Lupin Ltd, Alembic Pharms Ltd, and Prinston Inc. and is included in eight NDAs.

The generic ingredient in VALSARTAN AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; valsartan. There are thirty-one drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; valsartan profile page.

Summary for Tradename: VALSARTAN AND HYDROCHLOROTHIAZIDE

Patents:0
Applicants:8
NDAs:8
Suppliers / Packagers: see list22
Bulk Api Vendors: see list1
Clinical Trials: see list104,427
Patent Applications: see list10
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VALSARTAN AND HYDROCHLOROTHIAZIDE at DailyMed

Pharmacology for Tradename: VALSARTAN AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic Pharms Ltd
VALSARTAN AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; valsartan
TABLET;ORAL201662-002Mar 21, 2013ABRXNoNo► Subscribe► Subscribe
Lupin Ltd
VALSARTAN AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; valsartan
TABLET;ORAL078946-001Mar 21, 2013ABRXNoNo► Subscribe► Subscribe
Alembic Pharms Ltd
VALSARTAN AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; valsartan
TABLET;ORAL201662-003Mar 21, 2013ABRXNoNo► Subscribe► Subscribe
Lupin Ltd
VALSARTAN AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; valsartan
TABLET;ORAL078946-005Mar 21, 2013ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
VALSARTAN AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; valsartan
TABLET;ORAL202519-001Mar 21, 2013ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Baxter
US Department of Justice
Dow
Teva
Fuji
Merck
Federal Trade Commission
Julphar
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot